| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Wall Street Journal 2007 Technology Innovation Winners
Posted on 09/24/2007 22:06:46 | Link | Post Comment
by H.S. Ayoub, DMD
BioHealth Investor
The Wall Street Journal announced its annual Technology Innovation Winners of 2007. Here are the winners and runners-up in the Medical/Biotech and Medical Devices categories:
MEDICAL/BIOTECH
Winner:
Novarits (NVS) & Speedel (J6H1.F)
For finding a new approach to lowering high blood pressure. Novartis licensed Tekturna to Speedel to manufacture commercial quantities, then Novartis bought the drug back in 2002.
Runners-Up:
Genaco Biomedical Products, a unit of Qiagen (QGEN)
Using a single test to identify infectious organisms
Shire (SHPGY)
Treatment for Hunter syndrome, Elaprase
Abbott Laboratories (ABT)
Self-injectable treatment for Crohn's Disease, Humira
Schering-Plough (SGP)
Treatment for invasive fungal infections, Noxafil
MEDICAL DEVICES
Winner:
SeQual Technologies
The Eclipse, a 17-pound portable system that can provide concentrated oxygen for therapy.
Runners-UP:
Fonar (FONR)
Upright MRI, with improved imaging for babies, negating use of sedation.
Kyphon (KYPH)
Titanium implate to treat symptoms of lumber spoinal stenosis, X-Stop.
BioHealth Investor.com
________________
BioHealth Investor
The Wall Street Journal announced its annual Technology Innovation Winners of 2007. Here are the winners and runners-up in the Medical/Biotech and Medical Devices categories:
MEDICAL/BIOTECH
Winner:
Novarits (NVS) & Speedel (J6H1.F)
For finding a new approach to lowering high blood pressure. Novartis licensed Tekturna to Speedel to manufacture commercial quantities, then Novartis bought the drug back in 2002.
Runners-Up:
Genaco Biomedical Products, a unit of Qiagen (QGEN)
Using a single test to identify infectious organisms
Shire (SHPGY)
Treatment for Hunter syndrome, Elaprase
Abbott Laboratories (ABT)
Self-injectable treatment for Crohn's Disease, Humira
Schering-Plough (SGP)
Treatment for invasive fungal infections, Noxafil
MEDICAL DEVICES
Winner:
SeQual Technologies
The Eclipse, a 17-pound portable system that can provide concentrated oxygen for therapy.
Runners-UP:
Fonar (FONR)
Upright MRI, with improved imaging for babies, negating use of sedation.
Kyphon (KYPH)
Titanium implate to treat symptoms of lumber spoinal stenosis, X-Stop.
BioHealth Investor.com
________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
Examples
ATM Wallstreet - Tue Jul 08, 2008 02:28PM
Why I traded the stock ME today. I had it on my list fr [read more]
Why I traded the stock ME today. I had it on my list fr [read more]
Morpheus Trading - Thu Jul 03, 2008 07:49AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Sun Jul 06, 2008 11:00PM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
<< My Home | TheMoneyBlogs Home